303 related articles for article (PubMed ID: 1358042)
1. Survival in a cohort of human immunodeficiency virus-infected tuberculosis patients in New York City. Implications for the expansion of the AIDS case definition.
Stoneburner R; Laroche E; Prevots R; Singh T; Blum S; Terry P; Reatrice S; Adler J
Arch Intern Med; 1992 Oct; 152(10):2033-7. PubMed ID: 1358042
[TBL] [Abstract][Full Text] [Related]
2. Isoniazid preventive therapy in human immunodeficiency virus-infected persons. Long-term effect on development of tuberculosis and survival.
Moreno S; Miralles P; Diaz MD; Baraia J; Padilla B; Berenguer J; Alberdi JC
Arch Intern Med; 1997 Aug 11-25; 157(15):1729-34. PubMed ID: 9250234
[TBL] [Abstract][Full Text] [Related]
3. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection.
Selwyn PA; Alcabes P; Hartel D; Buono D; Schoenbaum EE; Klein RS; Davenny K; Friedland GH
N Engl J Med; 1992 Dec; 327(24):1697-703. PubMed ID: 1359411
[TBL] [Abstract][Full Text] [Related]
4. [Survival of patients with HIV-related tuberculosis. Study of mortality during the first 9 months of treatment].
Falqués Casanovas M; Langohr K; Gómez Melis G; García de Olalla Rizo P; Jansà López del Vallado JM; Caylà Buqueras JA
Rev Esp Salud Publica; 1999; 73(5):549-62. PubMed ID: 10650746
[TBL] [Abstract][Full Text] [Related]
5. Distribution of CD4+ T lymphocytes at diagnosis of acquired immunodeficiency syndrome-defining and other human immunodeficiency virus-related illnesses. The Adult and Adolescent Spectrum of HIV Disease Project Group.
Hanson DL; Chu SY; Farizo KM; Ward JW
Arch Intern Med; 1995 Jul; 155(14):1537-42. PubMed ID: 7605156
[TBL] [Abstract][Full Text] [Related]
6. Secular trends in the survival of HIV-infected homosexual men in Amsterdam and Vancouver estimated from a death-included CD4-staged Markov model.
Hendriks JC; Craib KJ; Veugelers PJ; van Druten HA; Coutinho RA; Schechter MT; van Griensven GJ
Int J Epidemiol; 2000 Jun; 29(3):565-72. PubMed ID: 10869332
[TBL] [Abstract][Full Text] [Related]
7. Neonatal predictors of infection status and early death among 332 infants at risk of HIV-1 infection monitored prospectively from birth. New York City Perinatal HIV Transmission Collaborative Study Group.
Abrams EJ; Matheson PB; Thomas PA; Thea DM; Krasinski K; Lambert G; Shaffer N; Bamji M; Hutson D; Grimm K
Pediatrics; 1995 Sep; 96(3 Pt 1):451-8. PubMed ID: 7651777
[TBL] [Abstract][Full Text] [Related]
8. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
[TBL] [Abstract][Full Text] [Related]
9. Tuberculosis should not be considered an AIDS-defining illness in areas with a high tuberculosis prevalence.
Badri M; Ehrlich R; Pulerwitz T; Wood R; Maartens G
Int J Tuberc Lung Dis; 2002 Mar; 6(3):231-7. PubMed ID: 11934141
[TBL] [Abstract][Full Text] [Related]
10. The natural history of human immunodeficiency virus infection among adults in Mumbai.
Hira SK; Shroff HJ; Lanjewar DN; Dholkia YN; Bhatia VP; Dupont HL
Natl Med J India; 2003; 16(3):126-31. PubMed ID: 12929853
[TBL] [Abstract][Full Text] [Related]
11. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and outcome of human immunodeficiency virus-infected patients with sporadic multidrug-resistant tuberculosis in New York City.
Mannheimer SB; Sepkowitz KA; Stoeckle M; Friedman CR; Hafner A; Riley LW
Int J Tuberc Lung Dis; 1997 Aug; 1(4):319-25. PubMed ID: 9432387
[TBL] [Abstract][Full Text] [Related]
13. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
[TBL] [Abstract][Full Text] [Related]
14. Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection.
Caiaffa WT; Graham NM; Galai N; Rizzo RT; Nelson KE; Vlahov D
Arch Intern Med; 1995 Oct; 155(19):2111-7. PubMed ID: 7575072
[TBL] [Abstract][Full Text] [Related]
15. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
Chaisson RE; Keruly J; Richman DD; Moore RD
Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
[TBL] [Abstract][Full Text] [Related]
16. T-lymphocytopaenia, opportunistic infections and pathological findings in Ghanaian AIDS patients and their sexual partners.
Ayisi NK; Wiredu EK; Sata T; Nyadedzor C; Tsiagbe VK; Newman M; Cofie CN; Taneguchi K
East Afr Med J; 1997 Dec; 74(12):784-91. PubMed ID: 9557423
[TBL] [Abstract][Full Text] [Related]
17. Use of beta 2-microglobulin level and CD4 lymphocyte count to predict development of acquired immunodeficiency syndrome in persons with human immunodeficiency virus infection.
Anderson RE; Lang W; Shiboski S; Royce R; Jewell N; Winkelstein W
Arch Intern Med; 1990 Jan; 150(1):73-7. PubMed ID: 1967523
[TBL] [Abstract][Full Text] [Related]
18. Relapse of tuberculosis after treatment in human immunodeficiency virus-infected patients.
Pulido F; Peña JM; Rubio R; Moreno S; González J; Guijarro C; Costa JR; Vázquez JJ
Arch Intern Med; 1997 Jan; 157(2):227-32. PubMed ID: 9009982
[TBL] [Abstract][Full Text] [Related]
19. Association between tuberculosis and HIV disease progression in a high tuberculosis prevalence area.
Badri M; Ehrlich R; Wood R; Pulerwitz T; Maartens G
Int J Tuberc Lung Dis; 2001 Mar; 5(3):225-32. PubMed ID: 11326821
[TBL] [Abstract][Full Text] [Related]
20. Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease.
Graham NM; Galai N; Nelson KE; Astemborski J; Bonds M; Rizzo RT; Sheeley L; Vlahov D
Arch Intern Med; 1996 Apr; 156(8):889-94. PubMed ID: 8774208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
